Twist Bioscience Corporation (TWST) Gross margin 2017–2025
Twist Bioscience Corporation (TWST) gross margin by fiscal year — reported gross profit divided by reported revenue.
50.7%FY2025 · since FY2017: -123.1% → 50.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 50.7% | +8.1 pp |
| FY2024 | 42.6% | +6.0 pp |
| FY2023 | 36.6% | -4.8 pp |
| FY2022 | 41.4% | +2.3 pp |
| FY2021 | 39.1% | +7.2 pp |
| FY2020 | 31.8% | +19.1 pp |
| FY2019 | 12.8% | +39.4 pp |
| FY2018 | -26.6% | +96.5 pp |
| FY2017 | -123.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Operating incomeTWST Operating marginTWST Operating cash flowTWST Free cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →